[Skip to Content]
[Skip to Content Landing]
September 19, 2007

Frequent Nocturnal Hemodialysis—A Step Forward?

Author Affiliations

Author Affiliations: Hospital of St. Raphael and Yale University, New Haven, Connecticut.

JAMA. 2007;298(11):1331-1333. doi:10.1001/jama.298.11.1331

Dialysis treatments sustain the lives of nearly 400 000 US residents with end-stage renal disease (ESRD).1 The mortality rate for dialysis patients is approximately 10 times that of the general population,2,3 and each year more than 20% of dialysis patients die.1 These statistics have hardly changed in the past decade. Morbidity also remains high: dialysis patients frequently also have cardiovascular disease, anemia, bone disease, poor nutrition, inflammation, depression, and physical and cognitive impairment.

First Page Preview View Large
First page PDF preview
First page PDF preview